INCT_FUNVIR

Brilacidin, a new antifungal drug to treat cryptococcosis journals.asm.org/doi/epub/10.11…

Hello, medical mycology enthusiasts!!! How about learn more about our logo? #fungus #mycology #inct

Meet our team! 🔬 Hello medical mycology enthusiasts! In this post we will introduce the coordinator of @inct_funvir, Professor Gustavo H. Goldman

For more informations about FUNVIR and possibilities of collaborating and interacting with this FUNVIR, please contact Prof. Gustavo H. Goldman ([email protected]).

3) to identify and propose new antifungal compounds and/or chemicals that can potentiate the pharmacological action of the current antifungal drugs; and 4) to investigate and advance the study of the immunology and the relatioship host-pathogen.

FUNVIR has the main aims: 1) to characterize mechanisms of virulence and pathogenicity in human pathogenic fungi; 2) to elucidate mechanisms of antifungal tolerance and drug resistance;

FUNVIR It is sponsored by the Brazilian CNPq, CAPES, and FAPESP, and coordinated by Prof. Gustavo H. Goldman, Universidade de São Paulo, Brazil. FUNVIR members Interact with more than 50 international centers all around the world, including South America, USA, China, and Europe.